🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/03/2019 | 117,76 | 119,27 | 116,36 | 118,85 | +0,93% | 2,47% | 311.000 |
| 15/03/2019 | 117,12 | 118,33 | 116,67 | 117,76 | +0,62% | 1,42% | 622.500 |
| 14/03/2019 | 115,42 | 117,27 | 114,59 | 117,03 | +1,27% | 2,32% | 379.600 |
| 13/03/2019 | 111,77 | 118,09 | 111,17 | 115,56 | +3,77% | 6,19% | 725.000 |
| 12/03/2019 | 112,51 | 112,78 | 110,70 | 111,36 | -0,42% | 1,85% | 673.800 |
| 11/03/2019 | 110,69 | 112,59 | 110,44 | 111,83 | +1,10% | 1,94% | 440.100 |
| 08/03/2019 | 110,72 | 111,34 | 109,62 | 110,61 | -0,41% | 1,55% | 369.100 |
| 07/03/2019 | 110,98 | 111,90 | 109,39 | 111,06 | -0,12% | 2,26% | 500.300 |
| 06/03/2019 | 115,02 | 116,29 | 111,01 | 111,19 | -3,65% | 4,59% | 659.900 |
| 05/03/2019 | 119,82 | 119,88 | 115,02 | 115,40 | -3,93% | 4,06% | 905.400 |
| 04/03/2019 | 127,76 | 127,98 | 119,84 | 120,12 | -5,30% | 6,37% | 497.800 |
| 01/03/2019 | 126,65 | 128,94 | 126,51 | 126,84 | +0,44% | 1,92% | 516.100 |
| 28/02/2019 | 125,34 | 127,95 | 124,85 | 126,29 | +0,60% | 2,47% | 385.600 |
| 27/02/2019 | 127,53 | 127,53 | 119,56 | 125,54 | +2,94% | 6,25% | 488.200 |
| 26/02/2019 | 119,60 | 122,60 | 119,25 | 121,95 | +1,74% | 2,80% | 494.200 |
| 25/02/2019 | 118,82 | 120,26 | 118,35 | 119,87 | +1,33% | 1,61% | 345.300 |
| 22/02/2019 | 117,58 | 118,31 | 116,09 | 118,30 | +1,09% | 1,89% | 242.700 |
| 21/02/2019 | 117,49 | 118,16 | 116,26 | 117,02 | -0,74% | 1,62% | 163.900 |
| 20/02/2019 | 118,83 | 119,18 | 117,59 | 117,89 | -0,74% | 1,34% | 171.300 |
| 19/02/2019 | 118,91 | 119,67 | 117,64 | 118,77 | -0,72% | 1,71% | 215.500 |
| 15/02/2019 | 119,05 | 119,65 | 118,34 | 119,63 | +0,92% | 1,10% | 227.100 |
| 14/02/2019 | 117,65 | 119,48 | 117,65 | 118,54 | +0,65% | 1,56% | 186.100 |
| 13/02/2019 | 118,47 | 118,99 | 117,12 | 117,78 | -0,28% | 1,58% | 204.800 |
| 12/02/2019 | 117,91 | 118,53 | 116,78 | 118,11 | +0,52% | 1,48% | 210.300 |
| 11/02/2019 | 116,67 | 118,19 | 116,45 | 117,50 | +0,88% | 1,49% | 202.600 |
| 08/02/2019 | 114,89 | 116,89 | 114,58 | 116,48 | +1,02% | 2,01% | 305.800 |
| 07/02/2019 | 116,35 | 116,93 | 114,83 | 115,30 | -1,03% | 1,80% | 217.700 |
| 06/02/2019 | 116,95 | 118,04 | 115,66 | 116,50 | -0,38% | 2,04% | 220.900 |
| 05/02/2019 | 116,90 | 118,15 | 116,26 | 116,95 | +0,06% | 1,62% | 289.700 |
| 04/02/2019 | 115,50 | 116,93 | 114,32 | 116,88 | +0,91% | 2,26% | 150.200 |